This Solicitation opportunity from Department Of Health And Human Services was posted on October 22, 2024. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Democratized Engineering of Cells Informed by Dynamic Evidence (DECIDE) Exploration Topic
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The Democratized Engineering of Cells Informed by Dynamic Evidence (DECIDE) Exploration Topic is a solicitation initiative launched by the Advanced Research Projects Agency for Health (ARPA-H), part of the Department of Health and Human Services. The primary objective of this exploration topic is to facilitate access to clinically validated curative cell therapies for pediatric patients suffering from rare genetic diseases. This will be achieved by developing innovative quality assurance mechanisms in Academic Medical Centers. The initiative represents an expansion of the funding strategies employed by ARPA-H's Resilient System Office, as detailed in the appended sections of the Master Announcement Instructions ARPA-H-MAI-24-01. A draft solicitation was amended on October 11, 2024, updating the proposal submission deadline to November 18, 2024, at 12:00 PM EST, and revising the anticipated release date to October 22, 2024. The solicitation was officially posted on October 22, 2024. The National Institutes of Health's most advanced research unit, ARPA-H, is responsible for this solicitation. The solicitation has been classified under the NAICS code 541715, implying a focus on research and development in the physical, engineering, and life sciences. The procurement process is active, and potential respondents are directed to submit their proposals by the stated deadline. The solicitation does not specify a set-aside type, suggesting an open competition for providing solutions related to this initiative. The office managing this solicitation is located in Bethesda, Maryland, USA.
General Info
Place of Performance
MD, USASet-Aside
Documents
12AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Submission Closed
Organization & Contact Information
Full Description
10/22/2024: Final solicitation posted
Amendment 1 to Draft Solicitation (10/11/2024): The purpose of this amendment is to update the Proposal Due Date to November 18, 2024 at 12pm EST. The anticipated solicitation release date was also updated to October 22, 2024.
Overview: ARPA-H is launching an Exploration Topic that aims to enable pediatric patients with rare genetic diseases to access clinically validated curative cell therapies by advancing novel quality assurance mechanisms at Academic Medical Centers (AMC). This ET expands the Resilient System Office’s (RSO) funding approach associated with the interest areas included within Appendix A to the Master Announcement Instructions, ARPA-H-MAI-24-01.
More opportunities from Department Of Health And Human Services → NATIONAL INSTITUTES OF HEALTH
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
